A covalent organic framework-based fluorescent immunosensor for selective NGAL detection enabling diabetic kidney disease stratification
- 1 January 2026
- journal article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
Abstract
A covalent organic framework based fluorescent immunosensor enables rapid stratification of diabetic kidney disease with >90% sensitivity, specificity and accuracy.Keywords
Funding Information
- Anusandhan National Research Foundation (ANRF/ECRG/2024/003811/CS)
This publication has 29 references indexed in Scilit:
- Fluorescence bioimaging of drug nanocarriers based on Förster resonance energy transfer, aggregation-induced emission and aggregation-caused quenchingActa Pharmaceutica Sinica B, 2025
- Nitrogen doped graphene quantum dots for sensitive and label-free fluorescence based biosensing of GE11 peptideColloids and Surfaces A: Physicochemical and Engineering Aspects, 2025
- The NGAL as a prognostic biomarker of kidney injury in children and adolescents with type 1 diabetes mellitus: A systematic review and meta-analysisJournal of Diabetes and its Complications, 2025
- Tailored Anti‐miR Decorated Covalent Organic Framework Enables Electrochemical Detection of Salivary miRNAs for Mild Traumatic Brain InjurySmall, 2025
- Visualization of carboxylesterase 2 regulation in kidney injury via an enzyme-activated fluorescent probeSensors and Actuators B: Chemical, 2025
- Study Design of a Nationwide Network Indian Cohort of Pregnancy-Associated Acute Kidney Injury (iPRAKI NET)Kidney International Reports, 2024
- Advances in aggregation-induced emission luminogens for biomedicine: From luminescence mechanisms to diagnostic applicationsBiosensors and Bioelectronics, 2024
- Bimodal Turn‐On Fluorescent Probe for Photophysical and Electrochemical Detection of Human Serum Albumin in Clinical SamplesAdvanced Materials Interfaces, 2022
- Selective pathological and intracellular detection of human serum albumin by photophysical and electrochemical techniques using a FRET-based molecular probeBiosensors and Bioelectronics, 2022
- Insights into the Role of Renal Biopsy in Patients with T2DM: A Literature Review of Global Renal Biopsy ResultsDiabetes Therapy, 2020